HCTI Sets Virtual Annual Meeting, Board Seeks Re-election & Auditor Ratification

TL;DR

**HCTI's board is playing it safe with a routine annual meeting, but the super-voting preferred stock means retail investors have minimal real power.**

AI Summary

Healthcare Triangle, Inc. (HCTI) is holding its 2025 Annual Meeting of Stockholders on November 7, 2025, virtually, to elect four director nominees and ratify SRCO Professional Corporation as its independent registered public accounting firm for the fiscal year ending December 31, 2025. The Board of Directors unanimously recommends voting FOR all proposals. As of October 15, 2025, the company has 5,873,304 shares of common stock and 20,000 shares of Series A Super Voting Preferred Stock outstanding, with preferred shares holding 1,000 votes each. The company is an 'emerging growth company' under the JOBS Act, allowing for reduced reporting requirements, including less disclosure on executive compensation and no non-binding advisory votes. Stockholders of record as of September 29, 2025, are eligible to vote, with proxies due by 11:59 p.m. Eastern Time on November 6, 2025.

Why It Matters

This DEF 14A filing outlines Healthcare Triangle's upcoming annual meeting, a crucial event for corporate governance and investor participation. The election of four directors, including Chairman Dave Rosa and COO Sujatha Ramesh, will shape the company's strategic direction and oversight for the next year. Ratifying SRCO Professional Corporation as the auditor provides essential financial transparency and external validation, impacting investor confidence. For employees and customers, stable leadership and robust financial controls signal a reliable and well-managed entity in the competitive healthcare technology sector.

Risk Assessment

Risk Level: medium — The presence of 20,000 shares of Series A Super Voting Preferred Stock, each carrying 1,000 votes, significantly concentrates voting power, potentially diluting the influence of common stockholders. This structure, combined with the company's 'emerging growth company' status allowing reduced executive compensation disclosure, presents a medium risk for governance transparency and common shareholder influence.

Analyst Insight

Investors should carefully review the biographies of the four director nominees to understand their qualifications and potential impact on company strategy. Given the super-voting preferred stock, common shareholders should focus on the board's recommendations and the auditor's role in ensuring financial integrity, as their direct voting power is limited.

Key Numbers

• 4 — Number of director nominees (To be elected at the 2025 Annual Meeting)
• 5,873,304 — Shares of common stock outstanding (As of October 15, 2025, with 1 vote per share)
• 20,000 — Shares of Series A Super Voting Preferred Stock outstanding (As of October 15, 2025, with 1,000 votes per share)
• 1,000 — Votes per share for preferred stock (Significantly concentrates voting power)
• 2025-11-07 — Date of Annual Meeting (Virtual meeting at 10:00 a.m. Pacific Time)
• 2025-09-29 — Record date for voting eligibility (Stockholders of record at close of business)
• 2025-11-06 — Proxy submission deadline (11:59 p.m. Eastern Time for internet/telephone proxies)
• 3 — Number of independent directors (Out of 4 total board members, per Nasdaq standards)

Key Players & Entities

• Healthcare Triangle, Inc. (company) — Registrant
• SRCO Professional Corporation, Chartered Professional Accountants (company) — Independent registered public accounting firm nominee
• Dave Rosa (person) — Chairman of the Board of Directors and director nominee
• Sujatha Ramesh (person) — Chief Operating Officer and director nominee
• Ronald McClurg (person) — Director nominee and Chairman of Compensation Committee
• Jainal Bhuiyan (person) — Director nominee and Chairman of Nominating and Corporate Governance Committee
• Securities and Exchange Commission (regulator) — Regulatory body
• $0.00001 (dollar_amount) — Par value per share for common and preferred stock
• $1.235 billion (dollar_amount) — Threshold for total annual gross revenue for an emerging growth company
• $700 million (dollar_amount) — Threshold for market value of common stock for a large accelerated filer

FAQ

Industry Context

Healthcare Triangle, Inc. operates within the healthcare technology sector, which is characterized by rapid innovation, evolving regulatory landscapes, and significant investment in digital transformation. Companies in this space often focus on solutions for data management, interoperability, and patient engagement. The industry is competitive, with a mix of established players and agile startups vying for market share.

Regulatory Implications

As a public company, Healthcare Triangle, Inc. is subject to SEC regulations, including the timely filing of proxy statements like this DEF 14A. Its status as an Emerging Growth Company under the JOBS Act allows for certain regulatory relief, particularly in executive compensation disclosures. Compliance with corporate governance standards and accurate financial reporting are critical to maintaining investor confidence.

What Investors Should Do

1. Vote on Director Nominees
2. Ratify Independent Auditors
3. Review Voting Power Concentration
4. Confirm Proxy Submission

Key Dates

• 2025-11-07: 2025 Annual Meeting of Stockholders — To elect directors and ratify the appointment of the independent registered public accounting firm.
• 2025-10-15: Proxy materials made available to stockholders — Marks the beginning of the proxy solicitation period and provides stockholders with information for the upcoming meeting.
• 2025-10-15: Mailing of Notice of Internet Availability of Proxy Materials — Informs stockholders of record and beneficial owners about the availability of proxy materials online.
• 2025-09-29: Record date for voting eligibility — Determines which stockholders are eligible to vote at the 2025 Annual Meeting.
• 2025-11-06: Proxy submission deadline — The deadline for stockholders to submit their votes via internet or telephone, ensuring their participation in the meeting's decisions.

Glossary

DEF 14A

A proxy statement filed with the SEC by publicly traded companies to solicit shareholder votes for an annual meeting. (This document contains the information presented in this analysis, detailing the agenda and proposals for Healthcare Triangle, Inc.'s 2025 Annual Meeting.)

Emerging Growth Company

A designation under the JOBS Act for companies with less than $1.235 billion in annual gross revenue, allowing for reduced reporting and disclosure requirements. (Healthcare Triangle, Inc. qualifies as an EGC, impacting the level of detail provided in its SEC filings, particularly regarding executive compensation.)

Series A Super Voting Preferred Stock

A class of preferred stock with significantly enhanced voting rights, in this case, 1,000 votes per share compared to one vote per common share. (This type of stock concentrates substantial voting power in the hands of its holders, potentially influencing the outcome of shareholder votes.)

Quorum

The minimum number of shares entitled to vote that must be present at a meeting (in person, by remote communication, or by proxy) for business to be legally transacted. (A quorum is required for the 2025 Annual Meeting to be valid, and it is defined as a majority of the outstanding shares entitled to vote.)

Year-Over-Year Comparison

This filing pertains to the 2025 Annual Meeting, and specific comparative financial metrics to a prior year's filing are not detailed within this DEF 14A excerpt. However, the company's status as an 'emerging growth company' suggests a potentially less extensive disclosure history compared to larger, more established entities, particularly concerning executive compensation details.

Key Financial Figures

• $0.00001 — 04 shares of common stock, par value of $0.00001 per share (“ common stock ”
• $1.235 b — total annual gross revenue of at least $1.235 billion, or (c) in which we are deemed to
• $700 million — that is held by non-affiliates exceeds $700 million as of the prior June 30th, and (y) the
• $1.0 billion — date on which we have issued more than $1.0 billion in non-convertible debt during the prio
• $3B — mature enterprises, totaling more than $3B in transactions. He holds FINRA Series

Filing Documents

• ea0261382-def14a_healthcare.htm (DEF 14A) — 163KB
• image_001.jpg (GRAPHIC) — 3KB
• image_002.jpg (GRAPHIC) — 338KB
• image_003.jpg (GRAPHIC) — 178KB
• 0001213900-25-099128.txt ( ) — 859KB

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 13 PROPOSAL TWO: RATIFICATION OF THE APPOINTMENT OF OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 14 Policy on Audit Committee Pre-Approval of Audit and Permissible Non-Audit Services of Independent Registered Public Accounting Firm 15 TRANSACTION OF OTHER BUSINESS 16 OTHER INFORMATION 16 Availability of Bylaws 16 2024 Annual Report 16 i HEALTHCARE TRIANGLE, INC. PROXY STATEMENT FOR THE 2025 ANNUAL MEETING OF STOCKHOLDERS TO BE HELD NOVEMBER 7, 2025 GENERAL INFORMATION Our Board of Directors has made this Proxy Statement and related materials available to you on the Internet, or at your request has delivered printed versions to you by mail, in connection with the Board of Directors’ solicitation of proxies for our 2025 Annual Meeting of Stockholders (the “ Annual Meeting ”), and any adjournment of the Annual Meeting. If you requested printed versions of these materials by mail, they will also include a proxy card for the Annual Meeting. The Annual Meeting will be held at 10:00 a.m. Pacific Time on Friday, November 7, 2025. The Annual Meeting will be a virtual stockholders meeting held at https://web.viewproxy.com/HCTI/2025. We made this Proxy Statement available to stockholders beginning on October 15, 2025. Pursuant to rules adopted by the Securities and Exchange Commission (“ SEC ”), we are providing access to our proxy materials over the Internet. Accordingly, we are sending a Notice of Internet Availability of Proxy Materials (the “ Notice ”) to our stockholders of record and beneficial 15, 2025. IMPORTANT NOTICE REGARDING THE INTERNET AVAILABILITY OF PROXY MATERIALS FOR THE ANNUAL STOCKHOLDERS MEETING TO BE HELD ON NOVEMBER 7, 2025: This proxy statement, the accompanying proxy card

View Full Filing

View this DEF 14A filing on SEC EDGAR